Chlorambucil
โ ๏ธ Patient Safety Alert:
Patients on chlorambucil should seek urgent medical advice if their temperature rises above 37.5ยฐC (99.5ยฐF) or 38ยฐC (100.4ยฐF), or if they feel unwell (e.g. chills, sore throat, cough, diarrhoea, urinary frequency).
๐ Even minor infections can escalate rapidly due to myelosuppression.
๐ About
- Chlorambucil is an oral alkylating agent used mainly in haematological malignancies.
- Causes DNA cross-linking and strand breaks, preventing replication and triggering apoptosis.
- Always check the BNF entry before prescribing.
โ๏ธ Mode of Action
- Binds covalently to DNA bases โ causes cross-links and mispairing.
- Cell cycle non-specific but preferentially affects rapidly dividing cells.
๐ฏ Indications / Dose
- Dosing is specialist-led and given orally.
- Hodgkinโs disease.
- Non-Hodgkinโs lymphoma (selected types).
- Chronic lymphocytic leukaemia (CLL).
- Waldenstrรถmโs macroglobulinaemia.
๐ค Interactions
- See BNF for full details.
- Other myelosuppressive or immunosuppressive drugs increase toxicity risk.
โ ๏ธ Cautions
- Oral anti-cancer medicines carry a high risk of dosing errors โ doses must be double-checked.
- Monitor full blood counts closely.
- Carcinogenic potential with long-term use (risk of secondary malignancies).
๐ซ Contraindications
- Refer to BNF for full list.
- Severe bone marrow suppression and active infection are key contraindications.
โ Side Effects
- Common: Anaemia, neutropenia, thrombocytopenia, nausea, vomiting, diarrhoea, oral ulcers.
- Serious: StevensโJohnson syndrome, infertility, seizures, secondary malignancies.
- Long-term: risk of myelodysplastic syndrome or acute leukaemia.
๐ References